ADJUVANT CHEMOTHERAPY
Clinical trials for ADJUVANT CHEMOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT CHEMOTHERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CHEMO-FREE HOPE: new trial tests skipping Post-Surgery drugs for colorectal cancer
Disease control Recruiting nowThis study is looking at whether people with locally advanced colorectal cancer who have already received chemotherapy or radiation before surgery can safely skip additional chemotherapy afterward. The trial will compare a 'wait and watch' approach to standard adjuvant chemothera…
Matched conditions: ADJUVANT CHEMOTHERAPY
Phase: NA • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New combo aims to wipe out hidden cancer cells after chemo
Disease control Recruiting nowThis study tests whether two drugs, fruquintinib and tislelizumab, can control leftover cancer cells in people with colorectal cancer who have completed chemotherapy but still show signs of minimal residual disease (MRD) on a blood test. About 20 adults with stable disease will r…
Matched conditions: ADJUVANT CHEMOTHERAPY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Blood test may help tailor chemo for colorectal cancer patients
Disease control Recruiting nowThis study is for people with stage I or low-risk stage II colorectal cancer who have a positive ctDNA blood test one month after surgery, indicating a higher risk of recurrence. Researchers will assign different chemotherapy regimens based on ctDNA results to see if this persona…
Matched conditions: ADJUVANT CHEMOTHERAPY
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New chemo combo could improve outcomes for stomach cancer patients
Disease control Recruiting nowThis phase 3 trial tests whether a chemotherapy combination of oxaliplatin plus S-1 works as well as or better than docetaxel plus S-1 for stage III gastric cancer patients who have had surgery. About 387 adults aged 18 to 80 will be randomly assigned to one of the two treatments…
Matched conditions: ADJUVANT CHEMOTHERAPY
Phase: PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC